https://imedic.health/en/health/news/retatrutide-phase-3-obesity-trial-triple-agonist-weight-loss iMedic en 2026-06-18 Retatrutide Phase 3 Trial: Triple-Agonist Obesity Drug Shows Surgery-Level Weight Loss https://imedic.health/en/health/news/public-led-exercise-review-heart-health-quality-of-life iMedic en 2026-06-18 Exercise, Heart Health and Quality of Life: Public-Led Review Aims to Clarify the Evidence https://imedic.health/en/health/news/brain-cooling-drugs-stroke-neuroprotection-mouse-study iMedic en 2026-06-18 Brain-Cooling Drugs for Stroke: New Neuroprotection Strategy Shows Early Promise https://imedic.health/en/health/news/circadian-rhythm-blood-sugar-control-type-2-diabetes iMedic en 2026-06-18 Circadian Rhythm and Type 2 Diabetes: Stable Sleep-Wake Patterns May Support Blood Sugar Control https://imedic.health/en/health/news/avalyn-pharma-fda-watch-inhaled-antifibrotic-pulmonary-fibrosis iMedic en 2026-06-18 Avalyn Pharma FDA Watch: Inhaled Antifibrotic Drugs for Pulmonary Fibrosis https://imedic.health/en/health/news/advanced-brain-tumor-imaging-mri-pet-treatment-planning iMedic en 2026-06-18 Advanced Brain Tumor Imaging: MRI, PET and Precision Treatment Planning https://imedic.health/en/health/news/golden-staph-bloodstream-infection-antibiotics-trial iMedic en 2026-06-18 Golden Staph Bloodstream Infection Antibiotics: Trial Points to Safer Treatment Choices https://imedic.health/en/health/news/exercise-mimetic-longevity-drug-metabolic-aging-research iMedic en 2026-06-18 Exercise-Mimetic Longevity Drug Research Tests a New Path for Healthy Aging https://imedic.health/en/health/news/childhood-depression-risk-eye-tracking-attention-patterns iMedic en 2026-06-19 Childhood Depression Risk and Eye-Tracking: Early Attention Patterns May Offer Clues https://imedic.health/en/health/news/wearable-health-tracking-anxiety-clinical-care iMedic en 2026-06-19 Wearable Health Tracking Anxiety: When Data Monitoring Needs Clinical Guidance https://imedic.health/en/health/news/emergency-blood-cell-production-aging-cancer-risk iMedic en 2026-06-19 Emergency Blood Cell Production May Reveal New Links Between Aging and Cancer https://imedic.health/en/health/news/retatrutide-type-2-diabetes-triple-agonist-treatment iMedic en 2026-06-19 Retatrutide for Type 2 Diabetes: Triple-Agonist Injection Targets Blood Sugar and Weight https://imedic.health/en/health/news/nitrate-rich-vegetables-oral-microbiome-blood-pressure iMedic en 2026-06-19 Nitrate-Rich Vegetables and Blood Pressure: Why Oral Bacteria May Matter https://imedic.health/en/health/news/triple-agonist-obesity-medicines-bariatric-surgery-weight-loss iMedic en 2026-06-19 Triple-Agonist Obesity Medicines May Narrow the Gap With Bariatric Surgery https://imedic.health/en/health/news/foodborne-illness-global-burden-children-food-safety iMedic en 2026-06-19 Foodborne Illness: Why Children Face the Highest Food Safety Risk https://imedic.health/en/health/news/cash-support-heart-failure-medication-adherence iMedic en 2026-06-19 Cash Support for Heart Failure Medications: Pilot Study Tests Adherence Strategy https://imedic.health/en/health/news/multiple-chronic-conditions-simpler-treatment-plans-physician-experience iMedic en 2026-06-19 Multiple Chronic Conditions: Why Simpler Treatment Plans Matter for Complex Patients https://imedic.health/en/health/news/pregnancy-mental-health-prevention-trial-anxiety-depression iMedic en 2026-06-19 Pregnancy Mental Health Trial Highlights Prevention for Anxiety and Depression https://imedic.health/en/health/news/doctor-experience-multimorbidity-primary-care-continuity iMedic en 2026-06-20 Multimorbidity Care: Doctor Experiences Point to Better Chronic Disease Follow-Up https://imedic.health/en/health/news/amylin-glp1-dual-hormone-diabetes-treatment iMedic en 2026-06-20 Amylin and GLP-1 Diabetes Therapy: Why Dual Hormone Treatment Is Drawing Attention https://imedic.health/en/health/news/epigenetic-age-tests-weight-loss-drugs-clinical-meaning iMedic en 2026-06-20 Epigenetic Age Tests and Weight-Loss Drugs: What the Biomarker Signal Means https://imedic.health/en/health/news/semaglutide-bone-fracture-risk-type-2-diabetes-real-world-study iMedic en 2026-06-20 Semaglutide and Bone Fracture Risk: Diabetes Study Signals Possible Added Protection https://imedic.health/en/health/news/glp1-medicines-aging-biomarkers-metabolic-health iMedic en 2026-06-20 GLP-1 Medicines and Aging Biomarkers: What Metabolic Health Can and Cannot Tell Us https://imedic.health/en/health/news/type-1-diabetes-staging-screening-beta-cell-preservation iMedic en 2026-06-20 Type 1 Diabetes Staging and Screening: Why Beta-Cell Preservation Matters https://imedic.health/en/health/news/over-the-counter-naloxone-nasal-spray-opioid-overdose-access iMedic en 2026-06-20 Over-the-Counter Naloxone Nasal Spray Expands Opioid Overdose Reversal Access